Introduced:
Sep 4, 2025
Policy Area:
Health
Congress.gov:
Bill Statistics
3
Actions
5
Cosponsors
0
Summaries
1
Subjects
1
Text Versions
Yes
Full Text
AI Summary
AI Summary
No AI Summary Available
Click the button above to generate an AI-powered summary of this bill using Claude.
The summary will analyze the bill's key provisions, impact, and implementation details.
Error generating summary
Latest Action
Sep 4, 2025
Referred to the House Committee on Energy and Commerce.
Actions (3)
Referred to the House Committee on Energy and Commerce.
Type: IntroReferral
| Source: House floor actions
| Code: H11100
Sep 4, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: Intro-H
Sep 4, 2025
Introduced in House
Type: IntroReferral
| Source: Library of Congress
| Code: 1000
Sep 4, 2025
Subjects (1)
Health
(Policy Area)
Cosponsors (5)
(R-FL)
Sep 4, 2025
Sep 4, 2025
(D-MD)
Sep 4, 2025
Sep 4, 2025
(D-CA)
Sep 4, 2025
Sep 4, 2025
(D-ME)
Sep 4, 2025
Sep 4, 2025
(R-NY)
Sep 4, 2025
Sep 4, 2025
Full Bill Text
Length: 1,725 characters
Version: Introduced in House
Version Date: Sep 4, 2025
Last Updated: Nov 13, 2025 6:32 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5160 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 5160
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 4, 2025
Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Bilirakis, Ms.
Pingree, Ms. Tenney, and Mr. Mfume) introduced the following bill;
which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
[From the U.S. Government Publishing Office]
[H.R. 5160 Introduced in House
(IH) ]
<DOC>
119th CONGRESS
1st Session
H. R. 5160
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
September 4, 2025
Mr. Smith of New Jersey (for himself, Ms. Matsui, Mr. Bilirakis, Ms.
Pingree, Ms. Tenney, and Mr. Mfume) introduced the following bill;
which was referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To reauthorize the Stem Cell Therapeutic and Research Act of 2005, and
for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
This Act may be cited as the ``Stem Cell Therapeutic and Research
Reauthorization Act of 2025''.
SEC. 2.
PROGRAM.
Section 379B of the Public Health Service Act (42 U.
amended--
(1) by striking ``appropriated $31,009,000'' and inserting
the following: ``appropriated--
``
(1) $31,009,000'';
(2) in paragraph
(1) , as so inserted, by striking the
period at the end and inserting ``; and''; and
(3) by adding at the end the following:
``
(2) $33,009,000 for each of fiscal years 2027 through
2031.''.
(1) by striking ``appropriated $31,009,000'' and inserting
the following: ``appropriated--
``
(1) $31,009,000'';
(2) in paragraph
(1) , as so inserted, by striking the
period at the end and inserting ``; and''; and
(3) by adding at the end the following:
``
(2) $33,009,000 for each of fiscal years 2027 through
2031.''.
SEC. 3.
Section 2
(g) of the Stem Cell Therapeutic and Research Act of 2005
(42 U.
(g) of the Stem Cell Therapeutic and Research Act of 2005
(42 U.S.C. 274k note) is amended by striking ``2026'' and inserting
``2031''.
<all>